Related references
Note: Only part of the references are listed.Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
Tomohiro Fukuda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Impact and risk factors of non-adherence to 5-aminosalicylates in quiescent ulcerative colitis evaluated by an electronic management system
M. P. Ballester et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
Long-term follow-up of patients treated with aminosalicylates for ulcerative colitis: Predictive factors of response: An observational case-control study
David Marti-Aguado et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)
Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission
Esther Garcia-Planella et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review
Mathurin Fumery et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial
Yasuo Suzuki et al.
INFLAMMATORY BOWEL DISEASES (2017)
The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry
Tomohiro Fukuda et al.
PLOS ONE (2017)
Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study
Masakazu Nagahori et al.
BMC GASTROENTEROLOGY (2017)
Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study
Michelle V. Prosberg et al.
INFLAMMATORY BOWEL DISEASES (2016)
Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications
James M. Richter et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis
T. Yamamoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis
Roberta Pica et al.
DIGESTIVE AND LIVER DISEASE (2015)
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
Brian Bressler et al.
GASTROENTEROLOGY (2015)
Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis
Kaoru Yokoyama et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids
Esther Garcia-Planella et al.
DIGESTIVE AND LIVER DISEASE (2012)
Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers
Alain M. Schoepfer et al.
JOURNAL OF CROHNS & COLITIS (2012)
Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids
C. Bello et al.
JOURNAL OF CROHNS & COLITIS (2011)
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
Laurent Peyrin-Biroulet et al.
JOURNAL OF CROHNS & COLITIS (2011)
Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts
S. V. Kane et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Effect of weekend 5-aminosalicylic acid (Mesalazine) enema as maintenance therapy for ulcerative colitis: Results from a Randomized controlled study
Hiroshi Yokoyama et al.
INFLAMMATORY BOWEL DISEASES (2007)
Ulcerative colitis:: Patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort
Ole Hoie et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
FS Velayos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Treatment of inflammatory bowel disease: Safety and tolerability issues
F Navarro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2003)
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
A Bitton et al.
GASTROENTEROLOGY (2001)
Share Paper
